ANIK Q1 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$37M+7.0% YoY

Gross Profit

$22M59.4% margin

Operating Income

-$4M-9.7% margin

Net Income

-$3M-8.0% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$342M

Total Liabilities

$56M

Stockholders' Equity

$286M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$34M	+7.0%
Gross Profit	$22M	$21M	+4.0%
Operating Income	-$4M	$1M	-382.5%
Net Income	-$3M	$3M	-203.3%

Revenue Segments

Product

$37M50%

OA Pain Management

$23M31%

Joint Preservation and Restoration

$12M17%

Non-Orthopedic

$2M2%

Geographic Segments

UNITED STATES

$27M82%

Europe

$6M18%